MDGL — Madrigal Pharmaceuticals, Inc. stock price, charts and financials

QT51Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
507.56
+25.56+5.30%
OverviewShort InterestFilings
MDGLQT51Madrigal Pharmaceuticals, Inc.·NASDAQ
507.56+5.30%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20268-KCurrent report
Jul 30, 202610-QQuarterly report
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 20, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 17, 2026S-8Registration of employee benefit securities
Jun 17, 20268-KCurrent report
Jun 01, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 06, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 28, 20268-KCurrent report
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 28, 2026ARSAnnual report to shareholders
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 06, 20264Statement of changes in beneficial ownership
#1 / 25 of 336
Page
▼
/ 14